Kayli Maney MD , Isabella K. Pallotto MPH , Simran Bansal BS , Shital Patel MD , Renée A. Shellhaas MD, MS , Zachary M. Grinspan MD, MS , Jeffrey Buchhalter MD, PhD , Elizabeth J. Donner MD, MSc , Gardiner Lapham MPH, RN , Thomas Stanton MPP , Monica E. Lemmon MD
{"title":"关于癫痫猝死的交流:对spike协议的适应。","authors":"Kayli Maney MD , Isabella K. Pallotto MPH , Simran Bansal BS , Shital Patel MD , Renée A. Shellhaas MD, MS , Zachary M. Grinspan MD, MS , Jeffrey Buchhalter MD, PhD , Elizabeth J. Donner MD, MSc , Gardiner Lapham MPH, RN , Thomas Stanton MPP , Monica E. Lemmon MD","doi":"10.1016/j.pediatrneurol.2024.10.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Sudden unexpected death in epilepsy (SUDEP) is a common cause of premature death in children and adults with epilepsy. People with epilepsy and their caregivers prefer the risk of SUDEP to be disclosed by their clinicians; however, few tools exist to support these conversations.</div></div><div><h3>Methods</h3><div>We aimed to (1) characterize SUDEP communication preferences of clinicians and caregivers of children with epilepsy, and (2) leverage these preferences to develop a conversation guide to support the discussion of SUDEP risk. We prospectively enrolled caregivers of children with epilepsy, child neurology clinicians, and child neurology trainees to participate in virtual focus groups and/or 1:1 interviews.</div></div><div><h3>Results</h3><div>Content was analyzed and collated into the following four domains: (1) <em>who should participate</em>: all participants described that the treating neurologist and/or epileptologist should lead conversations with patients and families. Caregivers preferred that clinicians disclose information about SUDEP to children only after asking permission. (2) <em>When and where conversations should occur</em>: most participants felt that the conversation should be discussed at the time of diagnosis and in the outpatient setting, (3) <em>content to include about SUDEP risk</em>: participants characterized the need to define SUDEP, what is known and unknown, as well as describe risk factors to reduce an individual child's risk, and (4) <em>barriers and facilitators to disclosure</em>: barriers included lack of time, limited evidence-based information regarding risk mitigation, lack of modifiable risk factors, and apprehension of causing undue stress on families. Participants shared that written material would help facilitate the discussion.</div></div><div><h3>Conclusions</h3><div>Caregivers and clinicians emphasized the value of SUDEP risk counseling in the pediatric clinical setting. Based on these findings, neurologists caring for children with epilepsy should educate caregivers about SUDEP soon after the initial epilepsy diagnosis in an empathetic manner, revisiting the conversation longitudinally over time and highlighting actionable steps to mitigate risk. Caregiver and clinician preferences informed our novel adaptation of the SPIKES protocol for use by pediatric neurologists in the context of SUDEP risk disclosure.</div></div>","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"163 ","pages":"Pages 50-57"},"PeriodicalIF":3.2000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Communication About Sudden Unexpected Death in Epilepsy: An Adaptation of the SPIKES Protocol\",\"authors\":\"Kayli Maney MD , Isabella K. Pallotto MPH , Simran Bansal BS , Shital Patel MD , Renée A. Shellhaas MD, MS , Zachary M. Grinspan MD, MS , Jeffrey Buchhalter MD, PhD , Elizabeth J. Donner MD, MSc , Gardiner Lapham MPH, RN , Thomas Stanton MPP , Monica E. Lemmon MD\",\"doi\":\"10.1016/j.pediatrneurol.2024.10.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Sudden unexpected death in epilepsy (SUDEP) is a common cause of premature death in children and adults with epilepsy. People with epilepsy and their caregivers prefer the risk of SUDEP to be disclosed by their clinicians; however, few tools exist to support these conversations.</div></div><div><h3>Methods</h3><div>We aimed to (1) characterize SUDEP communication preferences of clinicians and caregivers of children with epilepsy, and (2) leverage these preferences to develop a conversation guide to support the discussion of SUDEP risk. We prospectively enrolled caregivers of children with epilepsy, child neurology clinicians, and child neurology trainees to participate in virtual focus groups and/or 1:1 interviews.</div></div><div><h3>Results</h3><div>Content was analyzed and collated into the following four domains: (1) <em>who should participate</em>: all participants described that the treating neurologist and/or epileptologist should lead conversations with patients and families. Caregivers preferred that clinicians disclose information about SUDEP to children only after asking permission. (2) <em>When and where conversations should occur</em>: most participants felt that the conversation should be discussed at the time of diagnosis and in the outpatient setting, (3) <em>content to include about SUDEP risk</em>: participants characterized the need to define SUDEP, what is known and unknown, as well as describe risk factors to reduce an individual child's risk, and (4) <em>barriers and facilitators to disclosure</em>: barriers included lack of time, limited evidence-based information regarding risk mitigation, lack of modifiable risk factors, and apprehension of causing undue stress on families. Participants shared that written material would help facilitate the discussion.</div></div><div><h3>Conclusions</h3><div>Caregivers and clinicians emphasized the value of SUDEP risk counseling in the pediatric clinical setting. Based on these findings, neurologists caring for children with epilepsy should educate caregivers about SUDEP soon after the initial epilepsy diagnosis in an empathetic manner, revisiting the conversation longitudinally over time and highlighting actionable steps to mitigate risk. Caregiver and clinician preferences informed our novel adaptation of the SPIKES protocol for use by pediatric neurologists in the context of SUDEP risk disclosure.</div></div>\",\"PeriodicalId\":19956,\"journal\":{\"name\":\"Pediatric neurology\",\"volume\":\"163 \",\"pages\":\"Pages 50-57\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric neurology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0887899424003606\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric neurology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0887899424003606","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Communication About Sudden Unexpected Death in Epilepsy: An Adaptation of the SPIKES Protocol
Background
Sudden unexpected death in epilepsy (SUDEP) is a common cause of premature death in children and adults with epilepsy. People with epilepsy and their caregivers prefer the risk of SUDEP to be disclosed by their clinicians; however, few tools exist to support these conversations.
Methods
We aimed to (1) characterize SUDEP communication preferences of clinicians and caregivers of children with epilepsy, and (2) leverage these preferences to develop a conversation guide to support the discussion of SUDEP risk. We prospectively enrolled caregivers of children with epilepsy, child neurology clinicians, and child neurology trainees to participate in virtual focus groups and/or 1:1 interviews.
Results
Content was analyzed and collated into the following four domains: (1) who should participate: all participants described that the treating neurologist and/or epileptologist should lead conversations with patients and families. Caregivers preferred that clinicians disclose information about SUDEP to children only after asking permission. (2) When and where conversations should occur: most participants felt that the conversation should be discussed at the time of diagnosis and in the outpatient setting, (3) content to include about SUDEP risk: participants characterized the need to define SUDEP, what is known and unknown, as well as describe risk factors to reduce an individual child's risk, and (4) barriers and facilitators to disclosure: barriers included lack of time, limited evidence-based information regarding risk mitigation, lack of modifiable risk factors, and apprehension of causing undue stress on families. Participants shared that written material would help facilitate the discussion.
Conclusions
Caregivers and clinicians emphasized the value of SUDEP risk counseling in the pediatric clinical setting. Based on these findings, neurologists caring for children with epilepsy should educate caregivers about SUDEP soon after the initial epilepsy diagnosis in an empathetic manner, revisiting the conversation longitudinally over time and highlighting actionable steps to mitigate risk. Caregiver and clinician preferences informed our novel adaptation of the SPIKES protocol for use by pediatric neurologists in the context of SUDEP risk disclosure.
期刊介绍:
Pediatric Neurology publishes timely peer-reviewed clinical and research articles covering all aspects of the developing nervous system.
Pediatric Neurology features up-to-the-minute publication of the latest advances in the diagnosis, management, and treatment of pediatric neurologic disorders. The journal''s editor, E. Steve Roach, in conjunction with the team of Associate Editors, heads an internationally recognized editorial board, ensuring the most authoritative and extensive coverage of the field. Among the topics covered are: epilepsy, mitochondrial diseases, congenital malformations, chromosomopathies, peripheral neuropathies, perinatal and childhood stroke, cerebral palsy, as well as other diseases affecting the developing nervous system.